IBDEI0JQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9168,1,3,0)
 ;;=3^Clonic Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,9168,1,4,0)
 ;;=4^G51.3
 ;;^UTILITY(U,$J,358.3,9168,2)
 ;;=^5003995
 ;;^UTILITY(U,$J,358.3,9169,0)
 ;;=G51.4^^41^475^16
 ;;^UTILITY(U,$J,358.3,9169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9169,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,9169,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,9169,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,9170,0)
 ;;=G51.8^^41^475^17
 ;;^UTILITY(U,$J,358.3,9170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9170,1,3,0)
 ;;=3^Facial Nerve Disorders NEC
 ;;^UTILITY(U,$J,358.3,9170,1,4,0)
 ;;=4^G51.8
 ;;^UTILITY(U,$J,358.3,9170,2)
 ;;=^5003997
 ;;^UTILITY(U,$J,358.3,9171,0)
 ;;=H34.01^^41^475^53
 ;;^UTILITY(U,$J,358.3,9171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9171,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,9171,1,4,0)
 ;;=4^H34.01
 ;;^UTILITY(U,$J,358.3,9171,2)
 ;;=^5005553
 ;;^UTILITY(U,$J,358.3,9172,0)
 ;;=H34.02^^41^475^52
 ;;^UTILITY(U,$J,358.3,9172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9172,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,9172,1,4,0)
 ;;=4^H34.02
 ;;^UTILITY(U,$J,358.3,9172,2)
 ;;=^5005554
 ;;^UTILITY(U,$J,358.3,9173,0)
 ;;=G45.3^^41^475^3
 ;;^UTILITY(U,$J,358.3,9173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9173,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,9173,1,4,0)
 ;;=4^G45.3
 ;;^UTILITY(U,$J,358.3,9173,2)
 ;;=^304129
 ;;^UTILITY(U,$J,358.3,9174,0)
 ;;=H53.2^^41^475^12
 ;;^UTILITY(U,$J,358.3,9174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9174,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,9174,1,4,0)
 ;;=4^H53.2
 ;;^UTILITY(U,$J,358.3,9174,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,9175,0)
 ;;=H47.11^^41^475^37
 ;;^UTILITY(U,$J,358.3,9175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9175,1,3,0)
 ;;=3^Papilledema Associated w/ Increased Intracranial Pressure
 ;;^UTILITY(U,$J,358.3,9175,1,4,0)
 ;;=4^H47.11
 ;;^UTILITY(U,$J,358.3,9175,2)
 ;;=^269212
 ;;^UTILITY(U,$J,358.3,9176,0)
 ;;=H47.20^^41^475^35
 ;;^UTILITY(U,$J,358.3,9176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9176,1,3,0)
 ;;=3^Optic Atrophy,Unspec
 ;;^UTILITY(U,$J,358.3,9176,1,4,0)
 ;;=4^H47.20
 ;;^UTILITY(U,$J,358.3,9176,2)
 ;;=^5006126
 ;;^UTILITY(U,$J,358.3,9177,0)
 ;;=H47.321^^41^475^15
 ;;^UTILITY(U,$J,358.3,9177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9177,1,3,0)
 ;;=3^Drusen of Optic Disc,Right Eye
 ;;^UTILITY(U,$J,358.3,9177,1,4,0)
 ;;=4^H47.321
 ;;^UTILITY(U,$J,358.3,9177,2)
 ;;=^5006141
 ;;^UTILITY(U,$J,358.3,9178,0)
 ;;=H47.322^^41^475^14
 ;;^UTILITY(U,$J,358.3,9178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9178,1,3,0)
 ;;=3^Drusen of Optic Disc,Left Eye
 ;;^UTILITY(U,$J,358.3,9178,1,4,0)
 ;;=4^H47.322
 ;;^UTILITY(U,$J,358.3,9178,2)
 ;;=^5006142
 ;;^UTILITY(U,$J,358.3,9179,0)
 ;;=H47.323^^41^475^13
 ;;^UTILITY(U,$J,358.3,9179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9179,1,3,0)
 ;;=3^Drusen of Optic Disc,Bilateral
 ;;^UTILITY(U,$J,358.3,9179,1,4,0)
 ;;=4^H47.323
 ;;^UTILITY(U,$J,358.3,9179,2)
 ;;=^5006143
 ;;^UTILITY(U,$J,358.3,9180,0)
 ;;=H47.331^^41^475^43
 ;;^UTILITY(U,$J,358.3,9180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9180,1,3,0)
 ;;=3^Pseudopapilledema of Optic Disc,Right Eye
 ;;^UTILITY(U,$J,358.3,9180,1,4,0)
 ;;=4^H47.331
 ;;^UTILITY(U,$J,358.3,9180,2)
 ;;=^5006145
 ;;^UTILITY(U,$J,358.3,9181,0)
 ;;=H47.332^^41^475^42
 ;;^UTILITY(U,$J,358.3,9181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9181,1,3,0)
 ;;=3^Pseudopapilledema of Optic Disc,Left Eye
